Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women

NCT01833663 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder
Postmenopausal Disorder
Urination Disorders

Interventions

DRUG: Solifenacin Succinate Tablets
DRUG: Estrogen

Sponsor

Peking Union Medical College Hospital

Collaborators

[object Object]
[object Object]